0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA-Encoded Library (DEL) Technology Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-28Y16599
Home | Market Reports | Science| Biological Sciences
Global DNA Encoded Library DEL Technology Market Research Report 2024
BUY CHAPTERS

Global DNA-Encoded Library (DEL) Technology Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-28Y16599
Report
November 2025
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

DNA-Encoded Library (DEL) Technology Market

The global DNA-Encoded Library (DEL) Technology market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
The principle of DNA Encoded Library (DEL) technology is to label each small molecule compound in the reaction process with a small specific DNA sequence, and use the "Split and Pool" strategy of combinatorial chemistry to synthesize compound libraries with DNA sequences of millions or even billions in size. Affinity screening was performed between the DNA coding compound library and the target protein. Compounds that did not effectively bind to the target protein were eluted and removed, resulting in a collection of compounds that can bind to the protein. The DNA sequences of these compounds were amplified and amplified using Polymerase, and then detected by second-generation gene sequencing. Because the DNA sequences correspond one-to-one with small molecule compounds, researchers only need to read the DNA sequences on the molecules that bind to the target protein to decode the molecular structural formula that binds to the target protein.
From a downstream perspective, Pharmaceutical Company accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
DNA-Encoded Library (DEL) Technology leading manufacturers including HitGen, X-Chem, Amgen(Nuevolution), Vipergen, WuXi AppTec, Philochem, DICE THERAPEUTICS, HotSpot Therapeutics(Macroceutics), Dynabind, etc., dominate supply; the top five capture approximately % of global revenue, with HitGen leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DNA-Encoded Library (DEL) Technology market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of DNA-Encoded Library (DEL) Technology Market Report

Report Metric Details
Report Name DNA-Encoded Library (DEL) Technology Market
Segment by Type
  • Screening Service
  • DNA-encoded Library Customized Service
  • Other
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company HitGen, X-Chem, Amgen(Nuevolution), Vipergen, WuXi AppTec, Philochem, DICE THERAPEUTICS, HotSpot Therapeutics(Macroceutics), Dynabind
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the DNA-Encoded Library (DEL) Technology study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the DNA-Encoded Library (DEL) Technology Market report?

Ans: The main players in the DNA-Encoded Library (DEL) Technology Market are HitGen, X-Chem, Amgen(Nuevolution), Vipergen, WuXi AppTec, Philochem, DICE THERAPEUTICS, HotSpot Therapeutics(Macroceutics), Dynabind

What are the Application segmentation covered in the DNA-Encoded Library (DEL) Technology Market report?

Ans: The Applications covered in the DNA-Encoded Library (DEL) Technology Market report are Pharmaceutical Company, Biotechnology Company, Other

What are the Type segmentation covered in the DNA-Encoded Library (DEL) Technology Market report?

Ans: The Types covered in the DNA-Encoded Library (DEL) Technology Market report are Screening Service, DNA-encoded Library Customized Service, Other

1 Study Coverage
1.1 Introduction to DNA-Encoded Library (DEL) Technology: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global DNA-Encoded Library (DEL) Technology Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Screening Service
1.2.3 DNA-encoded Library Customized Service
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global DNA-Encoded Library (DEL) Technology Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DNA-Encoded Library (DEL) Technology Revenue Estimates and Forecasts 2020-2031
2.2 Global DNA-Encoded Library (DEL) Technology Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global DNA-Encoded Library (DEL) Technology Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global DNA-Encoded Library (DEL) Technology Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Screening Service Market Size by Players
3.3.2 DNA-encoded Library Customized Service Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global DNA-Encoded Library (DEL) Technology Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global DNA-Encoded Library (DEL) Technology Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global DNA-Encoded Library (DEL) Technology Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America DNA-Encoded Library (DEL) Technology Market Size by Type (2020-2031)
6.4 North America DNA-Encoded Library (DEL) Technology Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America DNA-Encoded Library (DEL) Technology Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe DNA-Encoded Library (DEL) Technology Market Size by Type (2020-2031)
7.4 Europe DNA-Encoded Library (DEL) Technology Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe DNA-Encoded Library (DEL) Technology Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific DNA-Encoded Library (DEL) Technology Market Size by Type (2020-2031)
8.4 Asia-Pacific DNA-Encoded Library (DEL) Technology Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific DNA-Encoded Library (DEL) Technology Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America DNA-Encoded Library (DEL) Technology Market Size by Type (2020-2031)
9.4 Central and South America DNA-Encoded Library (DEL) Technology Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America DNA-Encoded Library (DEL) Technology Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa DNA-Encoded Library (DEL) Technology Market Size by Type (2020-2031)
10.4 Middle East and Africa DNA-Encoded Library (DEL) Technology Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa DNA-Encoded Library (DEL) Technology Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 HitGen
11.1.1 HitGen Corporation Information
11.1.2 HitGen Business Overview
11.1.3 HitGen DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.1.4 HitGen DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.1.5 HitGen DNA-Encoded Library (DEL) Technology Revenue by Product in 2024
11.1.6 HitGen DNA-Encoded Library (DEL) Technology Revenue by Application in 2024
11.1.7 HitGen DNA-Encoded Library (DEL) Technology Revenue by Geographic Area in 2024
11.1.8 HitGen DNA-Encoded Library (DEL) Technology SWOT Analysis
11.1.9 HitGen Recent Developments
11.2 X-Chem
11.2.1 X-Chem Corporation Information
11.2.2 X-Chem Business Overview
11.2.3 X-Chem DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.2.4 X-Chem DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.2.5 X-Chem DNA-Encoded Library (DEL) Technology Revenue by Product in 2024
11.2.6 X-Chem DNA-Encoded Library (DEL) Technology Revenue by Application in 2024
11.2.7 X-Chem DNA-Encoded Library (DEL) Technology Revenue by Geographic Area in 2024
11.2.8 X-Chem DNA-Encoded Library (DEL) Technology SWOT Analysis
11.2.9 X-Chem Recent Developments
11.3 Amgen(Nuevolution)
11.3.1 Amgen(Nuevolution) Corporation Information
11.3.2 Amgen(Nuevolution) Business Overview
11.3.3 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.3.4 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.3.5 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology Revenue by Product in 2024
11.3.6 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology Revenue by Application in 2024
11.3.7 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology Revenue by Geographic Area in 2024
11.3.8 Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology SWOT Analysis
11.3.9 Amgen(Nuevolution) Recent Developments
11.4 Vipergen
11.4.1 Vipergen Corporation Information
11.4.2 Vipergen Business Overview
11.4.3 Vipergen DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.4.4 Vipergen DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.4.5 Vipergen DNA-Encoded Library (DEL) Technology Revenue by Product in 2024
11.4.6 Vipergen DNA-Encoded Library (DEL) Technology Revenue by Application in 2024
11.4.7 Vipergen DNA-Encoded Library (DEL) Technology Revenue by Geographic Area in 2024
11.4.8 Vipergen DNA-Encoded Library (DEL) Technology SWOT Analysis
11.4.9 Vipergen Recent Developments
11.5 WuXi AppTec
11.5.1 WuXi AppTec Corporation Information
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.5.4 WuXi AppTec DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.5.5 WuXi AppTec DNA-Encoded Library (DEL) Technology Revenue by Product in 2024
11.5.6 WuXi AppTec DNA-Encoded Library (DEL) Technology Revenue by Application in 2024
11.5.7 WuXi AppTec DNA-Encoded Library (DEL) Technology Revenue by Geographic Area in 2024
11.5.8 WuXi AppTec DNA-Encoded Library (DEL) Technology SWOT Analysis
11.5.9 WuXi AppTec Recent Developments
11.6 Philochem
11.6.1 Philochem Corporation Information
11.6.2 Philochem Business Overview
11.6.3 Philochem DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.6.4 Philochem DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.6.5 Philochem Recent Developments
11.7 DICE THERAPEUTICS
11.7.1 DICE THERAPEUTICS Corporation Information
11.7.2 DICE THERAPEUTICS Business Overview
11.7.3 DICE THERAPEUTICS DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.7.4 DICE THERAPEUTICS DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.7.5 DICE THERAPEUTICS Recent Developments
11.8 HotSpot Therapeutics(Macroceutics)
11.8.1 HotSpot Therapeutics(Macroceutics) Corporation Information
11.8.2 HotSpot Therapeutics(Macroceutics) Business Overview
11.8.3 HotSpot Therapeutics(Macroceutics) DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.8.4 HotSpot Therapeutics(Macroceutics) DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.8.5 HotSpot Therapeutics(Macroceutics) Recent Developments
11.9 Dynabind
11.9.1 Dynabind Corporation Information
11.9.2 Dynabind Business Overview
11.9.3 Dynabind DNA-Encoded Library (DEL) Technology Product Features and Attributes
11.9.4 Dynabind DNA-Encoded Library (DEL) Technology Revenue and Gross Margin (2020-2025)
11.9.5 Dynabind Recent Developments
12 DNA-Encoded Library (DEL) TechnologyIndustry Chain Analysis
12.1 DNA-Encoded Library (DEL) Technology Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 DNA-Encoded Library (DEL) Technology Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global DNA-Encoded Library (DEL) Technology Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global DNA-Encoded Library (DEL) Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global DNA-Encoded Library (DEL) Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global DNA-Encoded Library (DEL) Technology Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global DNA-Encoded Library (DEL) Technology Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global DNA-Encoded Library (DEL) Technology Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global DNA-Encoded Library (DEL) Technology Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global DNA-Encoded Library (DEL) Technology by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA-Encoded Library (DEL) Technology as of 2024)
 Table 11. Global DNA-Encoded Library (DEL) Technology Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global DNA-Encoded Library (DEL) Technology Companies Headquarters
 Table 13. Global DNA-Encoded Library (DEL) Technology Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global DNA-Encoded Library (DEL) Technology Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global DNA-Encoded Library (DEL) Technology Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global DNA-Encoded Library (DEL) Technology Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global DNA-Encoded Library (DEL) Technology Revenue by Application (2026-2031) & (US$ Million)
 Table 21. DNA-Encoded Library (DEL) Technology High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America DNA-Encoded Library (DEL) Technology Growth Accelerators and Market Barriers
 Table 25. North America DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe DNA-Encoded Library (DEL) Technology Growth Accelerators and Market Barriers
 Table 27. Europe DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific DNA-Encoded Library (DEL) Technology Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America DNA-Encoded Library (DEL) Technology Investment Opportunities and Key Challenges
 Table 31. Central and South America DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa DNA-Encoded Library (DEL) Technology Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa DNA-Encoded Library (DEL) Technology Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. HitGen Corporation Information
 Table 35. HitGen Description and Major Businesses
 Table 36. HitGen Product Features and Attributes
 Table 37. HitGen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. HitGen Revenue Proportion by Product in 2024
 Table 39. HitGen Revenue Proportion by Application in 2024
 Table 40. HitGen Revenue Proportion by Geographic Area in 2024
 Table 41. HitGen DNA-Encoded Library (DEL) Technology SWOT Analysis
 Table 42. HitGen Recent Developments
 Table 43. X-Chem Corporation Information
 Table 44. X-Chem Description and Major Businesses
 Table 45. X-Chem Product Features and Attributes
 Table 46. X-Chem Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. X-Chem Revenue Proportion by Product in 2024
 Table 48. X-Chem Revenue Proportion by Application in 2024
 Table 49. X-Chem Revenue Proportion by Geographic Area in 2024
 Table 50. X-Chem DNA-Encoded Library (DEL) Technology SWOT Analysis
 Table 51. X-Chem Recent Developments
 Table 52. Amgen(Nuevolution) Corporation Information
 Table 53. Amgen(Nuevolution) Description and Major Businesses
 Table 54. Amgen(Nuevolution) Product Features and Attributes
 Table 55. Amgen(Nuevolution) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Amgen(Nuevolution) Revenue Proportion by Product in 2024
 Table 57. Amgen(Nuevolution) Revenue Proportion by Application in 2024
 Table 58. Amgen(Nuevolution) Revenue Proportion by Geographic Area in 2024
 Table 59. Amgen(Nuevolution) DNA-Encoded Library (DEL) Technology SWOT Analysis
 Table 60. Amgen(Nuevolution) Recent Developments
 Table 61. Vipergen Corporation Information
 Table 62. Vipergen Description and Major Businesses
 Table 63. Vipergen Product Features and Attributes
 Table 64. Vipergen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Vipergen Revenue Proportion by Product in 2024
 Table 66. Vipergen Revenue Proportion by Application in 2024
 Table 67. Vipergen Revenue Proportion by Geographic Area in 2024
 Table 68. Vipergen DNA-Encoded Library (DEL) Technology SWOT Analysis
 Table 69. Vipergen Recent Developments
 Table 70. WuXi AppTec Corporation Information
 Table 71. WuXi AppTec Description and Major Businesses
 Table 72. WuXi AppTec Product Features and Attributes
 Table 73. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. WuXi AppTec Revenue Proportion by Product in 2024
 Table 75. WuXi AppTec Revenue Proportion by Application in 2024
 Table 76. WuXi AppTec Revenue Proportion by Geographic Area in 2024
 Table 77. WuXi AppTec DNA-Encoded Library (DEL) Technology SWOT Analysis
 Table 78. WuXi AppTec Recent Developments
 Table 79. Philochem Corporation Information
 Table 80. Philochem Description and Major Businesses
 Table 81. Philochem Product Features and Attributes
 Table 82. Philochem Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Philochem Recent Developments
 Table 84. DICE THERAPEUTICS Corporation Information
 Table 85. DICE THERAPEUTICS Description and Major Businesses
 Table 86. DICE THERAPEUTICS Product Features and Attributes
 Table 87. DICE THERAPEUTICS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. DICE THERAPEUTICS Recent Developments
 Table 89. HotSpot Therapeutics(Macroceutics) Corporation Information
 Table 90. HotSpot Therapeutics(Macroceutics) Description and Major Businesses
 Table 91. HotSpot Therapeutics(Macroceutics) Product Features and Attributes
 Table 92. HotSpot Therapeutics(Macroceutics) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. HotSpot Therapeutics(Macroceutics) Recent Developments
 Table 94. Dynabind Corporation Information
 Table 95. Dynabind Description and Major Businesses
 Table 96. Dynabind Product Features and Attributes
 Table 97. Dynabind Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Dynabind Recent Developments
 Table 99. Raw Materials Key Suppliers
 Table 100. Distributors List
 Table 101. Market Trends and Market Evolution
 Table 102. Market Drivers and Opportunities
 Table 103. Market Challenges, Risks, and Restraints
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources


List of Figures
 Figure 1. DNA-Encoded Library (DEL) Technology Product Picture
 Figure 2. Global DNA-Encoded Library (DEL) Technology Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Screening Service Product Picture
 Figure 4. DNA-encoded Library Customized Service Product Picture
 Figure 5. Other Product Picture
 Figure 6. Global DNA-Encoded Library (DEL) Technology Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pharmaceutical Company
 Figure 8. Biotechnology Company
 Figure 9. Other
 Figure 10. DNA-Encoded Library (DEL) Technology Report Years Considered
 Figure 11. Global DNA-Encoded Library (DEL) Technology Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 13. Global DNA-Encoded Library (DEL) Technology Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global DNA-Encoded Library (DEL) Technology Revenue Market Share by Region (2020-2031)
 Figure 15. Global DNA-Encoded Library (DEL) Technology Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Screening Service Revenue Market Share by Player in 2024
 Figure 18. DNA-encoded Library Customized Service Revenue Market Share by Player in 2024
 Figure 19. Other Revenue Market Share by Player in 2024
 Figure 20. Global DNA-Encoded Library (DEL) Technology Revenue Market Share by Type (2020-2031)
 Figure 21. Global DNA-Encoded Library (DEL) Technology Revenue Market Share by Application (2020-2031)
 Figure 22. North America DNA-Encoded Library (DEL) Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players DNA-Encoded Library (DEL) Technology Revenue (US$ Million) in 2024
 Figure 24. North America DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe DNA-Encoded Library (DEL) Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players DNA-Encoded Library (DEL) Technology Revenue (US$ Million) in 2024
 Figure 31. Europe DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 34. France DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific DNA-Encoded Library (DEL) Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players DNA-Encoded Library (DEL) Technology Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 46. India DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore DNA-Encoded Library (DEL) Technology Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America DNA-Encoded Library (DEL) Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players DNA-Encoded Library (DEL) Technology Revenue (US$ Million) in 2024
 Figure 54. Central and South America DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa DNA-Encoded Library (DEL) Technology Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players DNA-Encoded Library (DEL) Technology Revenue (US$ Million) in 2024
 Figure 60. South America DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa DNA-Encoded Library (DEL) Technology Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa DNA-Encoded Library (DEL) Technology Revenue (2020-2025) & (US$ Million)
 Figure 66. DNA-Encoded Library (DEL) Technology Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String